Literature DB >> 1640692

N,N'-diethyl-m-toluamide (m-DET): analysis of an insect repellent in human urine and serum by high-performance liquid chromatography.

A W Smallwood1, K E DeBord, L K Lowry.   

Abstract

A procedure for monitoring m-DET in human urine and serum is described. m-DET is removed from the urine specimen by partitioning into diethyl ether, but solid-phase extraction is used to remove it from human serum. The urine and serum m-DET values are determined by HPLC with a UV detector. The limit of detection was 0.09 micrograms/mL in urine and 0.09 micrograms/g for serum. The percent of m-DET recovered from human urine spiked between 0.50 and 8.00 micrograms/mL was 90 +/- 5.4%. For human serum spiked between 0.25 and 10.00, the percent recovered was 96 +/- 5.9%. The pooled relative standard deviations (RSD) for spiked matrices were 0.06 for urine and 0.06 for serum.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1640692     DOI: 10.1093/jat/16.1.10

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  3 in total

1.  On-line solid phase extraction-high performance liquid chromatography-isotope dilution-tandem mass spectrometry approach to quantify N,N-diethyl-m-toluamide and oxidative metabolites in urine.

Authors:  Peter Kuklenyik; Samuel E Baker; Amanda M Bishop; Pilar Morales-A; Antonia M Calafat
Journal:  Anal Chim Acta       Date:  2013-06-06       Impact factor: 6.558

2.  Assessment of dermal absorption of DEET-containing insect repellent and oxybenzone-containing sunscreen using human urinary metabolites.

Authors:  Lih-Ming Yiin; Jia-Ni Tian; Chien-Che Hung
Journal:  Environ Sci Pollut Res Int       Date:  2014-12-11       Impact factor: 4.223

3.  Development of an observational exposure human biomonitoring study to assess Canadian children's DEET exposure during protective use.

Authors:  Jennifer C Gibson; Leonora Marro; Michael M Borghese; Danielle Brandow; Lauren Remedios; Mandy Fisher; Morie Malowany; Katarzyna Kieliszkiewicz; Anna O Lukina; Kim Irwin
Journal:  PLoS One       Date:  2022-08-04       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.